LRG1: An emerging therapeutic target for the treatment of microvascular dysfunction
John Greenwood PhD and Stephen E. Moss PhD explore the imminent potential of LRG1 as a microvascular dysfunction treatment.
Computer science, software and mathematics: Interactive proof assistants
Dr Nicolas Tabareau from IMT Atlantique Bretagne-Pays de la Loire, provides us with further insight about interactive proof assistants, within the wider field of computer science, software and mathematics.
Doubly charged atomic negative ions for efficient tunable water oxidation to hydrogen peroxide
Drs Alfred Msezane and Kelvin Suggs discuss the possibilities of efficient tunable water oxidation to peroxide catalyzed by doubly charged atomic negative ions.
More organs may be suitable for transplantation with new perfusion method
More donated organs may become suitable for transplantation with a new perfusion method trialled by the EU-funded COPE project.
Digital twins – are they game-changers in clinical research and clinical care?
Prof Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH, explores if digital twins are game-changers in clinical research and clinical care.
Industrial policy including secure access to raw materials for batteries
Carlos Trias Pintó explains the European Economic and Social Committee’s stance on industrial policy, including strategies to secure access to raw materials for batteries.
Cambridge COVID-19 vaccine gets £1.9 million to start trials
The University of Cambridge are developing a COVID-19 vaccine, which is expected to start clinical trials in Autumn 2020.
Nightingale hospitals could increase antibiotic resistance
The University of Plymouth revealed that secondary COVID-19 treatment could be increasing antibiotic resistance and polluting water.
Broadening participation in U.S. astronomical research
Open Access Government explores the different ways that the National Science Foundation’s Division of Astronomical Sciences is encouraging wider participation and diversity in U.S. research.
Physics: Crucial questions about structure and our world
Denise Caldwell, Director, Division of Physics U.S. National Science Foundation (NSF), sheds light on research that addresses the most fundamental questions surrounding the structure and inner workings of our world.
Space: Morphology of impact craters from shaped penetrators
Here, M. Danner and R.M Winglee from Department of Earth and Space Sciences at the University of Washington, share their expertise on the morphology of impact craters from shaped penetrators.
£1 million for COVID-19 documentation project in Manchester
The University of Manchester recently won a grant of nearly £1 million, to support their ongoing COVID-19 documentation projection.
Antimicrobial nanocoatings: Functional and preventative benefits
Aarthi Janakiraman, Research Manager, Chemicals and Advanced Materials at TechVision, Frost & Sullivan, argues that antimicrobial nanocoatings will gain prominence due to their functional and preventative benefits.
One step closer to implanting diagnostic electronics in the body
The American Chemical Society (ACS) are closer to using electronics in the body, to diagnose tumours and track illnesses.
New cell injection technique could reverse vision loss
Researchers at the University of Toronto Engineering tried co-injection of both retinal pigmented epithelium (RPE) cells and photoreceptor cells to reverse vision loss.
Male bias in drug development trials creates overmedication
New research shows that the gender gap in drug development trials results in an overmedication of women by healthcare professionals.
The science behind the South Korea COVID-19 strategy
Jongeun You explains how the South Korea COVID-19 strategy flattened the curve, without destroying the economy.
World population predicted to shrink after the mid-century
According to a new study, world population will peak in 2064 at around 9.7 billion and then decline to 8.8 billion by 2100 – around 2 billion lower than previous estimates.
Single-cell genomics: Clinical strategies for COVID-19
Here, Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group argues that single-cell genomics empowers clinical strategies for COVID-19.
Brexit impact: Health and brain research
Prof Monica Di Luca, President, European Brain Council, sheds light on the greater impact of Brexit in terms of health and brain research being up for negotiation.
